Zobrazeno 1 - 10
of 90
pro vyhledávání: '"MESH: Kidney Neoplasms"'
Autor:
Thi Oanh Bui, Van Tu Dao, Van Tai Nguyen, Jean-Paul Feugeas, Frédéric Pamoukdjian, Guilhem Bousquet
Publikováno v:
European Urology
European Urology, 2022, 81 (4), pp.349-361. ⟨10.1016/j.eururo.2021.12.010⟩
European Urology, 2022, 81 (4), pp.349-361. ⟨10.1016/j.eururo.2021.12.010⟩
International audience; Context: Although antiangiogenic treatments and immunotherapies have significantly improved the prognosis of metastatic renal cell carcinoma (RCC), many patients will develop resistance, leading to treatment failure. Genetic t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6954158ec20fd4196a0ef261a1d75c22
https://doi.org/10.1016/j.eururo.2021.12.010
https://doi.org/10.1016/j.eururo.2021.12.010
Autor:
R. Guillon, Jean-Pierre Daurès, David Azria, S. Marchal, François Iborra, X. Rebillard, S.G. Trouche-sabatier, I. Serre, O. Lauche, tous les acteurs de l’onco-urologie de l’Hérault, A. Gevorgyan, D. Topart, R. Reis-Borges, G. Poinas, P.-J. Lamy, N. Abdo, Ingrid Millet, Brigitte Trétarre, O. Delbos
Publikováno v:
Progrès en Urologie
Progrès en Urologie, 2020, 30 (16), pp.1038-1044. ⟨10.1016/j.purol.2020.09.015⟩
Progrès en Urologie, 2020, 30 (16), pp.1038-1044. ⟨10.1016/j.purol.2020.09.015⟩
Resume Objectifs On observe dans l’Herault une nette augmentation de l’incidence des cancers urologiques. Le registre des tumeurs de l’Herault (RTH) a recueilli 1961 tumeurs urologiques en 2016, soit 21,4 % de l’ensemble des tumeurs de l’He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e238695281f593835aafddf6e1ba6b
https://doi.org/10.1016/j.purol.2020.09.015
https://doi.org/10.1016/j.purol.2020.09.015
Autor:
Sébastien Salas, Vanessa Cottet, Laure Dossus, Philippine Fassier, Julie Ginhac, Paule Latino-Martel, Isabelle Romieu, Stéphane Schneider, Bernard Srour, Marina Touillaud, Mathilde Touvier, Raphaëlle Ancellin
Publikováno v:
Nutrients
Nutrients, 2022, 14 (14), pp.2958. ⟨10.3390/nu14142958⟩
Nutrients, 2022, 14 (14), pp.2958. ⟨10.3390/nu14142958⟩
International audience; The French National Cancer Institute conducted a collective expertise study with researchers and clinical experts from the French Network for Nutrition And Cancer Research (NACRe Network). The objective was to update the state
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6c6f95e06a160fd132a999c6e0a54b7
https://doi.org/10.3390/nu14142958
https://doi.org/10.3390/nu14142958
Autor:
Yann‐Alexandre Vano, Letuan Phan, Gwenaelle Gravis, Iphigénie Korakis, Friederike Schlürmann, Denis Maillet, Mostefa Bennamoun, Nadine Houede, Delphine Topart, Delphine Borchiellini, Philippe Barthelemy, Raffaele Ratta, Thomas Ryckewaert, Ali Hasbini, Sophie Hans, Sheik Emambux, Sandra Cournier, Elena Braychenko, Réza‐Thierry Elaidi, Stéphane Oudard
Publikováno v:
International Journal of Cancer
International Journal of Cancer, 2022, 151 (8), pp.1335-1344. ⟨10.1002/ijc.34126⟩
International Journal of Cancer, 2022, 151 (8), pp.1335-1344. ⟨10.1002/ijc.34126⟩
International audience; Nivolumab and cabozantinib are approved agents in mRCC patients after sunitinib/pazopanib (TKI) failure. However, the optimal sequence, cabozantinib then nivolumab (CN) or nivolumab then cabozantinib (NC), is still unknown. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa55d6650cf0c7bac8f95d4bcfa5b53b
https://amu.hal.science/hal-04084994
https://amu.hal.science/hal-04084994
Autor:
Trouche-sabatier, S.G., Rebillard, X., Iborra, F., Azria, D., Daures, J.-P., Poinas, G., Abdo, N., Delbos, O., Gevorgyan, A., Marchal, S., Guillon, R., Millet, I., Lamy, P.-J., Lauche, O., Reis-Borges, R., Serre, I., Topart, D., Tretarre, B.
Publikováno v:
Progrès en Urologie
Progrès en Urologie, Elsevier Masson, 2020, 30 (16), pp.1038-1044. ⟨10.1016/j.purol.2020.09.015⟩
Progrès en Urologie, Elsevier Masson, 2020, 30 (16), pp.1038-1044. ⟨10.1016/j.purol.2020.09.015⟩
International audience; Purpose: In 2016, the Herault tumor registry collected 1961cancers in urology (21.4 % from all Herault cancers this year). RHESOU was created to complete RTH' data with specific parameters in onco-urology. The aim of this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::80e19eb10ec85d047440db434cdc9bec
https://pubmed.ncbi.nlm.nih.gov/33012630
https://pubmed.ncbi.nlm.nih.gov/33012630
Autor:
Annalisa Comandatore, Benoit Immordino, Rita Balsano, Mjriam Capula, Ingrid Garajovà, Joseph Ciccolini, Elisa Giovannetti, Luca Morelli
Publikováno v:
Diagnostics
Diagnostics, 2022, 12 (2), pp.286. ⟨10.3390/diagnostics12020286⟩
Comandatore, A, Immordino, B, Balsano, R, Capula, M, Garajovà, I, Ciccolini, J, Giovannetti, E & Morelli, L 2022, ' Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer ', Diagnostics (Basel, Switzerland), vol. 12, no. 2, 286 . https://doi.org/10.3390/diagnostics12020286
Diagnostics, 2022, 12 (2), pp.286. ⟨10.3390/diagnostics12020286⟩
Comandatore, A, Immordino, B, Balsano, R, Capula, M, Garajovà, I, Ciccolini, J, Giovannetti, E & Morelli, L 2022, ' Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer ', Diagnostics (Basel, Switzerland), vol. 12, no. 2, 286 . https://doi.org/10.3390/diagnostics12020286
International audience; In recent years, a growing number of studies have evaluated the role of exosomes in pancreatic ductal adenocarcinoma cancer (PDAC) demonstrating their involvement in a multitude of pathways, including the induction of chemores
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac30e6d8d42692a8cfe91c84be36e6cb
https://doi.org/10.3390/diagnostics12020286
https://doi.org/10.3390/diagnostics12020286
Autor:
El Bejjani, Marie-Rose
Publikováno v:
Médecine humaine et pathologie. 2016
Our objective was to compare DCEUS at one month and the CT-scan at 2 months for the prediction of response in patients treated by tyrosine kinase inhibitors for metastatic renal cell carcinoma.We performed DCE-US in one target at baseline and D30. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3d56ec7b1d4f5199743cf134c73a7d1a
https://dumas.ccsd.cnrs.fr/dumas-01429730/document
https://dumas.ccsd.cnrs.fr/dumas-01429730/document
Autor:
Lise Queiroz, Francis Bonnefoy, Béatrice Gaugler, Clémentine Gamonet, Sindy Vrecko, Olivier Adotevi, Eric Tartour, Antoine Thiery-Vuillemin, Thierry Nguyen Tan Hon, Jean-René Pallandre, Laura Mansi, Christophe Borg, Guillaume Mouillet, Patrice Ravel, Elsa Curtit, Yann Godet, Tristan Maurina, Jagadeesh Bayry, Caroline Laheurte, Elodie Lauret Marie-Joseph, Laura Boullerot, Bernard Royer, Xavier Pivot, Laurent Beziaud, L. Rangan
Publikováno v:
Cancer Research
Cancer Research, 2016, 76 (14), pp.4100-4112. ⟨10.1158/0008-5472.CAN-15-2452⟩
Cancer Research, American Association for Cancer Research, 2016, 76 (14), pp.4100-4112. ⟨10.1158/0008-5472.CAN-15-2452⟩
Cancer Research, 2016, 76 (14), pp.4100-4112. ⟨10.1158/0008-5472.CAN-15-2452⟩
Cancer Research, American Association for Cancer Research, 2016, 76 (14), pp.4100-4112. ⟨10.1158/0008-5472.CAN-15-2452⟩
The rapalogs everolimus and temsirolimus that inhibit mTOR signaling are used as antiproliferative drugs in several cancers. Here we investigated the influence of rapalogs-mediated immune modulation on their antitumor efficacy. Studies in metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02f2fa176a5697c8523397639af997f1
https://hal.umontpellier.fr/hal-02294356
https://hal.umontpellier.fr/hal-02294356
Autor:
Vitaly Margulis, Wassim Kassouf, Alon Z. Weizer, Armin Pycha, Thomas J. Walton, Richard Zigeuner, Yair Lotan, Karl Pummer, Vincenzo Ficarra, Harun Fajkovic, Pierre I. Karakiewicz, Kazumasa Matsumoto, Douglas S. Scherr, Eiji Kikuchi, Thomas F. Chromecki, Eugene K. Cha, Mesut Remzi, Jay D. Raman, Shahrokh F. Shariat, Marco Roscigno, Giacomo Novara, Karim Bensalah
Publikováno v:
European Urology
European Urology, Elsevier, 2012, 61 (2), pp.245-53. ⟨10.1016/j.eururo.2011.09.017⟩
European Urology, Elsevier, 2012, 61 (2), pp.245-53. ⟨10.1016/j.eururo.2011.09.017⟩
International audience; BACKGROUND: The prognostic impact of multifocal upper-tract urothelial carcinoma (UTUC) is poorly understood. OBJECTIVE: To investigate the association between tumor multifocality and clinicopathologic features and outcomes of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82bc7b222fadab3ad4d0f87d519c16b6
https://doi.org/10.1016/j.eururo.2011.09.017
https://doi.org/10.1016/j.eururo.2011.09.017
Autor:
Giovanni Lughezzani, Françoise Bouet, Nathalie Rioux-Leclercq, Jean Jacques Patard, B. Cipolla, Pierre I. Karakiewicz, Jean Philippe Moulinoux, Véronique Catros-Quemener, Paul Perrotte, Pierre Bigot
Publikováno v:
Journal of Urology
Journal of Urology, Elsevier, 2010, 183 (2), pp.486-91. ⟨10.1016/j.juro.2009.10.012⟩
Journal of Urology, 2010, 183 (2), pp.486-91. ⟨10.1016/j.juro.2009.10.012⟩
Journal of Urology, Elsevier, 2010, 183 (2), pp.486-91. ⟨10.1016/j.juro.2009.10.012⟩
Journal of Urology, 2010, 183 (2), pp.486-91. ⟨10.1016/j.juro.2009.10.012⟩
International audience; PURPOSE: The polyamines spermine and spermidine are ubiquitous polycationic structures which are essential for cell proliferation and differentiation. Circulating polyamines, spermine and spermidine, represent valuable prognos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a65a12e4497f8c281216e119b5eff2e
https://doi.org/10.1016/j.juro.2009.10.012
https://doi.org/10.1016/j.juro.2009.10.012